Annotation Detail

Information
Associated Genes
ELAC2
Associated Variants
ELAC2 MUTATION
ELAC2 MUTATION
Associated Disease
Malignant neoplasm of prostate
Source Database
DisGeNET
Description
The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients.
Pubmed
26251261
Section of the abstract supporting the evidence
ALL_TEXT_1/3
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
1
Original source reporting the Gene Disease association
BeFree,GAD
DisGENET score for the Gene Disease association
0.0581983144552528
Drugs